Current Digital Events
-
AFI organizes on Tuesday, April 21 from 16:00 to 17:30 the webinar Impact of Coronavirus emergency on patients involved in clinical trials. See more -
The Regulatory Authorities have required Pharmaceutical Companies to assess the risk of the possible presence of nitrosamines, potentially carcinogenic compounds, in medicinal products for human use and containing active ingredients derived from chemical synthesis. Aschimfarma and AFI, united in this particular period where finding new creative solutions is essential, invite to participate in the webinar to understand together what are the expectations of the Regulatory Agencies, also in light of the postponement of the evaluation period of the medicinal products manufactured (01 October 2020). See more -
WEBINAR – Clinical trial and Coronavirus emergency: drug management and Source Document Verification / InternetAFI and SIMeF organize a webinar for Clinical Research professionals to discuss best practices during the COVID-19 emergency period. It will discuss procedures, current regulations and guidelines of various regulatory authorities (AIFA, FDA, EMA) recently issued to ensure that patients and clinical trial data are safeguarded even in an unfavorable environment. Sponsors, clinical centers, regulatory authorities, EC, patients are involved in these processes. See more